TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) insider Gregory A. Firestone bought 2,600 shares of the business’s stock in a transaction on Tuesday, December 5th. The stock was bought at an average price of $5.65 per share, with a total value of $14,690.00. Following the purchase, the insider now owns 35,511 shares in the […]
Stonepine Capital Management LLC purchased a new stake in shares of TELA Bio, Inc. (NASDAQ:TELA – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 482,619 shares of the company’s stock, valued at approximately $4,889,000. TELA Bio accounts for […]
TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CEO Antony Koblish acquired 11,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The shares were purchased at an average cost of $4.54 per share, with a total value of $49,940.00. Following the completion of the acquisition, the chief executive officer […]
TELA Bio, Inc. (NASDAQ:TELA – Get Free Report) CFO Roberto Cuca purchased 10,000 shares of TELA Bio stock in a transaction that occurred on Tuesday, November 14th. The stock was acquired at an average cost of $4.49 per share, with a total value of $44,900.00. Following the acquisition, the chief financial officer now directly owns […]
TELA Bio (NASDAQ:TELA – Get Rating) and Utah Medical Products (NASDAQ:UTMD – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations. Profitability This table compares TELA Bio and Utah […]